American Journal of Obstetrics & Gynecology Mfm

Papers
(The H4-Index of American Journal of Obstetrics & Gynecology Mfm is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis690
Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals523
Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study242
Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples214
Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers a206
Coronavirus disease 2019 in pregnancy: early lessons124
Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy117
Labor and delivery guidance for COVID-19109
Pandemic-related pregnancy stress and anxiety among women pregnant during the coronavirus disease 2019 pandemic103
COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women101
Two cases of coronavirus 2019–related cardiomyopathy in pregnancy101
Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis88
Adherence and acceptability of telehealth appointments for high-risk obstetrical patients during the coronavirus disease 2019 pandemic82
Decreased incidence of preterm birth during coronavirus disease 2019 pandemic78
Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy76
Effects of psychological stress on adverse pregnancy outcomes and nonpharmacologic approaches for reduction: an expert review75
MFM guidance for COVID-1966
Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection55
Impact of labor and delivery unit policy modifications on maternal and neonatal outcomes during the coronavirus disease 2019 pandemic54
Early prediction of preeclampsia via machine learning50
COVID-19 vaccination in pregnancy: early experience from a single institution49
Severe acute respiratory distress syndrome in coronavirus disease 2019–infected pregnancy: obstetric and intensive care considerations48
Acceptance of COVID-19 vaccination in pregnancy: a survey study45
Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission43
Pregnant women's perspectives on severe acute respiratory syndrome coronavirus 2 vaccine42
COVID-19 vaccination among pregnant people in the United States: a systematic review41
Wireless, remote solution for home fetal and maternal heart rate monitoring41
Coronavirus disease 2019 vaccines in pregnancy40
Pregnancy as a risk factor for severe coronavirus disease 2019 using standardized clinical criteria40
Racial disparities in prematurity persist among women of high socioeconomic status40
False-negative testing for severe acute respiratory syndrome coronavirus 2: consideration in obstetrical care38
Exposure to toxic metals and per- and polyfluoroalkyl substances and the risk of preeclampsia and preterm birth in the United States: a review36
High antibody levels in cord blood from pregnant women vaccinated against COVID-1934
Coronavirus disease 2019 pregnancy outcomes in a racially and ethnically diverse population34
Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis34
0.047333955764771